Cargando…
Should reduction of increased short‐term blood pressure variability be a target of antihypertensive therapy?
It has long been known that blood pressure (BP) is characterized by marked short‐term fluctuations occurring within a 24‐h period and also by long‐term oscillations occurring over more prolonged periods of time. An increased short‐term blood pressure variability (BPV) appears to importantly contribu...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678723/ https://www.ncbi.nlm.nih.gov/pubmed/33538054 http://dx.doi.org/10.1111/jch.14210 |
_version_ | 1784616367880667136 |
---|---|
author | Mulè’, Giuseppe Sorce, Alessandra Vario, Maria Giovanna Giambrone, Marta Cottone, Santina |
author_facet | Mulè’, Giuseppe Sorce, Alessandra Vario, Maria Giovanna Giambrone, Marta Cottone, Santina |
author_sort | Mulè’, Giuseppe |
collection | PubMed |
description | It has long been known that blood pressure (BP) is characterized by marked short‐term fluctuations occurring within a 24‐h period and also by long‐term oscillations occurring over more prolonged periods of time. An increased short‐term blood pressure variability (BPV) appears to importantly contribute to target organ damage and to the enhanced cardiovascular risk of hypertensive patients, over and above the effect of an increase in mean BP levels. Reducing 24‐h mean BP is the main aim of antihypertensive therapy, but initial data are available that additional cardiovascular protection can be achieved by reducing BPV. However, to definitively prove the prognostic role of short‐term BPV and the need for its control by treatment, evidence is still needed from intervention trials aimed at demonstrating that by reducing BPV through administration of antihypertensive drugs, a reduction in organ damage and in the rate of cardiovascular events can be obtained. |
format | Online Article Text |
id | pubmed-8678723 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86787232021-12-23 Should reduction of increased short‐term blood pressure variability be a target of antihypertensive therapy? Mulè’, Giuseppe Sorce, Alessandra Vario, Maria Giovanna Giambrone, Marta Cottone, Santina J Clin Hypertens (Greenwich) Blood Pressure Variability It has long been known that blood pressure (BP) is characterized by marked short‐term fluctuations occurring within a 24‐h period and also by long‐term oscillations occurring over more prolonged periods of time. An increased short‐term blood pressure variability (BPV) appears to importantly contribute to target organ damage and to the enhanced cardiovascular risk of hypertensive patients, over and above the effect of an increase in mean BP levels. Reducing 24‐h mean BP is the main aim of antihypertensive therapy, but initial data are available that additional cardiovascular protection can be achieved by reducing BPV. However, to definitively prove the prognostic role of short‐term BPV and the need for its control by treatment, evidence is still needed from intervention trials aimed at demonstrating that by reducing BPV through administration of antihypertensive drugs, a reduction in organ damage and in the rate of cardiovascular events can be obtained. John Wiley and Sons Inc. 2021-02-04 /pmc/articles/PMC8678723/ /pubmed/33538054 http://dx.doi.org/10.1111/jch.14210 Text en © 2021 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Blood Pressure Variability Mulè’, Giuseppe Sorce, Alessandra Vario, Maria Giovanna Giambrone, Marta Cottone, Santina Should reduction of increased short‐term blood pressure variability be a target of antihypertensive therapy? |
title | Should reduction of increased short‐term blood pressure variability be a target of antihypertensive therapy? |
title_full | Should reduction of increased short‐term blood pressure variability be a target of antihypertensive therapy? |
title_fullStr | Should reduction of increased short‐term blood pressure variability be a target of antihypertensive therapy? |
title_full_unstemmed | Should reduction of increased short‐term blood pressure variability be a target of antihypertensive therapy? |
title_short | Should reduction of increased short‐term blood pressure variability be a target of antihypertensive therapy? |
title_sort | should reduction of increased short‐term blood pressure variability be a target of antihypertensive therapy? |
topic | Blood Pressure Variability |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678723/ https://www.ncbi.nlm.nih.gov/pubmed/33538054 http://dx.doi.org/10.1111/jch.14210 |
work_keys_str_mv | AT mulegiuseppe shouldreductionofincreasedshorttermbloodpressurevariabilitybeatargetofantihypertensivetherapy AT sorcealessandra shouldreductionofincreasedshorttermbloodpressurevariabilitybeatargetofantihypertensivetherapy AT variomariagiovanna shouldreductionofincreasedshorttermbloodpressurevariabilitybeatargetofantihypertensivetherapy AT giambronemarta shouldreductionofincreasedshorttermbloodpressurevariabilitybeatargetofantihypertensivetherapy AT cottonesantina shouldreductionofincreasedshorttermbloodpressurevariabilitybeatargetofantihypertensivetherapy |